Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Matrices
Reexamination Certificate
2011-05-24
2011-05-24
Lilling, Herbert J. (Department: 1657)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Matrices
C424S094600, C514S784000
Reexamination Certificate
active
07947306
ABSTRACT:
Methods for hydrolyzing solid ungranulated lysophosphatidylcholine with phospholipase A2are provided. Also disclosed are methods for making a lipid matrix of lysophosphatidylcholine, monoglyceride and fatty acid, and lipid matrices of particular structure.
REFERENCES:
patent: 4849132 (1989-07-01), Fujita et al.
patent: 4874795 (1989-10-01), Yesair
patent: 5314921 (1994-05-01), Yesair
patent: 5571517 (1996-11-01), Yesair
patent: 5612190 (1997-03-01), Arita et al.
patent: 5707873 (1998-01-01), Yesair
patent: 5716814 (1998-02-01), Yesair
patent: 5741822 (1998-04-01), Yesair
patent: 5891466 (1999-04-01), Yesair
patent: 5972911 (1999-10-01), Yesair
patent: 6426069 (2002-07-01), Yesair
patent: 2002/0071820 (2002-06-01), Afriat et al.
Bent, Elyssa D. et al., “Quantification of the interactions among fatty acid, lysophosphatidylcholine, calcium, dimyristoylphosphatidylcholine vesicles, and phospholipase A2,” Biochemica et Biophysica Acta1995; 1254:349-360.
Gregory, J.K. et al., “The Water Dipole Moment in Water Clusters,”ScienceFeb. 7, 1997; 275:814-817.
Hauser, H., “The Conformation of the Polar Group of Lecithin and Lysolecithin,”Journal of Colloid and Interface ScienceApr. 1976; 55(1):85-93.
Holt, Peter R. et al., “A Liquid Crystalline Phase in Human Intestinal Contents During Fat Digestion,”Lipids1986; 21(7):444-446.
Hui, S.W., “X-ray Diffraction Evidence for Fully Interdigitated Bilayers of 1-Stearoyllysophosphatidylcholine,”Biochemistry1986; 25:1330-1335.
Koo, Sung I. et al., “Effect of Zinc Deficiency on Intestinal Transport of Triglyceride in the Rat,”The Journal of NutritionMay 1977; 107(5):909-919.
Koo, Sung I. et al., “Effect of marginal zinc deficiency on the morphological characteristics of intestinal nascent chylomicrons and distribution of soluble apoproteins of lymph chylomicrons,”The American Journal of Clinical NutritionOct. 1985; 42:671-680.
Lepage, Guy et al., “Effect of an organized lipid matrix on lipid absorption and clinical outcomes in patients with cystic fibrosis,”The Journal of PediatricsAug. 2002; 141(2):178-185.
Rand, R.P. et al., “Structural Dimensions and Their Changes in a Reentrant Hexagonal-Lamellar Transition of Phospholipids,”Biophysical JournalJun. 1994; 66:2127-2138.
Rosevear, F.B. et al., “The Microscopy of the Liquid Crystalline Neat and Middle Phases of Soaps and Synthetic Detergents,”The Journal of the American Oil Chemists' SocietyDec. 1954; 31(12):628-639.
Robinson, N. et al., “The Physical Properties of Lysolecithin and its Sols,”Journal of Pharmacy and Pharmacology1959; 11:304-313.
Saunders, L., “Molecular Aggregation in Aqueous Dispersions of Phosphatidyl and Lysophosphatidyl Cholines,”Biochem. Biophys. Acta. 1996; 125:70-74.
Small, D.M., “The Physical Chemistry of Lipids from Alkanes to Phospholipids,” Handbook of Lipid Research 4, Plenum Press, New York, NY 1986, pp. 386-392, 475-517.
Wells, M.A. et al., “Studies on Phospholipase A.I. Isolation and Characterization of Two Enzymes fromCrotalus adamanteusVenom,”Biochemistry1696; 8(1):414-424.
[No Author Listed] Nutritional Reviews; Jun. 1984; 6(42):220-222.
Burgess Stephen W.
McKee Robert Travis
Shaw Walter A.
Yesair David W.
BioMolecular Products, Inc.
Lilling Herbert J.
Wolf Greenfield & Sacks P.C.
LandOfFree
Modifications of solid 3-sn-phosphoglycerides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modifications of solid 3-sn-phosphoglycerides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modifications of solid 3-sn-phosphoglycerides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2672427